Production (Stage)
Tectonic Therapeutic, Inc.
TECX
$21.65
-$0.55-2.48%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -34.56% | -35.40% | -18.19% | -- | -- |
| Total Depreciation and Amortization | 9.19% | 11.30% | 5.82% | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 120.09% | 503.77% | 194.86% | -- | -- |
| Change in Net Operating Assets | -3,069.05% | -1,659.93% | -275.40% | -- | -- |
| Cash from Operations | -60.68% | -45.23% | -46.44% | -- | -- |
| Capital Expenditure | -21.77% | 44.09% | 60.51% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -21.77% | 44.09% | 60.51% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -0.42% | 4.81% | 5.57% | -- | -- |
| Issuance of Common Stock | 704.58% | 184.19% | 13,156,900.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 13,912.09% | -- | -- | -- | -- |
| Cash from Financing | 955.04% | 408.83% | 41,317.73% | -- | -- |
| Foreign Exchange rate Adjustments | 205.00% | -150.00% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4,794.61% | 1,662.73% | 503.78% | -- | -- |